文献速递临床试验与 GCP真实世界研究与卫生经济

新型糖尿病治疗鞋预防足溃疡复发:开放标签随机对照试验方案

Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial.
PubMed 文献 · Trials · 2021-02-17

BACKGROUND: Recurrence after the healing of a foot ulcer is very common among patients with diabetes mellitus. Novel diabetic therapeutic footwear consisted of merino wool, vibration chip, and orthopedic insoles is designed to influence multifaceted mechanisms of foot ulcer occur…

要点

  • 新型治疗鞋由美利奴羊毛、振动芯片和矫形鞋垫组成,针对足溃疡发生的多重机制设计。
  • 主要结局为溃疡复发率,次要结局包括裸足动态足底压力、鞋具依从性对复发的影响及心血管事件发生率。

核心结论

  • 该试验将提供新型糖尿病治疗鞋预防有足溃疡史患者溃疡复发的效果信息。
  • 若该优化设计治疗鞋效果良好,将有助于开发预防高危患者足溃疡复发的创新治疗装置。

研究设计与样本

  • 纳入标准:伴糖尿病周围神经病变、随机化前3个月内足溃疡愈合、年龄≥18岁的成人。
  • 参与者随机接受新型糖尿病治疗鞋(n=160)或自备鞋(n=160)。
  • 样本量基于中国最新全国多中心糖尿病足溃疡调查数据采用Log-rank检验计算。
  • 评估访视和数据收集在基线、1、3、6、9和12个月进行,采用意向性治疗原则。

关键数值与推荐

  • 主要结局为溃疡复发率;次要结局为裸足动态足底压力测量、鞋具依从性对溃疡复发的影响及心血管事件发生率。
  • 采用Cox回归模型计算溃疡复发风险比,采用重复测量方差分析评估裸足动态足底压力变化。
  • 研究方案已获四川大学华西医院生物医学研究伦理委员会批准(批件号2019(96))。
  • 试验注册于中国临床试验注册中心ChiCTR1900025538,注册日期2019年8月31日。

临床怎么用

  • 该试验结果可为高危糖尿病患者选择治疗性鞋具预防足溃疡复发提供证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recurrence after the healing of a foot ulcer is very common among patients with diabetes mellitus. Novel diabetic therapeutic footwear consisted of merino wool, vibration chip, and orthopedic insoles is designed to influence multifaceted mechanisms of foot ulcer occurrence. The aim of this study is to examine the effect of the optimally designed therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulcers (DFU). METHODS/DESIGN: The trial is designed as a two arms, parallel-group, open-label randomized controlled intervention study. The Log-rank Test was used for calculating sample size based on the latest national multicenter survey data of DFU in China. Three hundred and twenty participants will be recruited from the Diabetic Foot Care Center, West China Hospital, Sichuan University. Adults with diabetic peripheral neuropathy, healed foot ulceration in the 3 months prior to randomization, and aged ≥18 years, will be recruited. Participants will be randomized to receive novel diabetic therapeutic footwear (n = 160) or their own footwear (n = 160). The primary outcome will be the incidence of ulcer recurrence. The secondary outcome will be measurements of barefoot dynamic plantar pressures, the influence of footwear adherence on ulcer recurrence, and the incidence of cardiovascular events. Assessment visits and data collection will be obtained at baseline, 1, 3, 6, 9, and 12 months. The intention-to-treat principle will be applied. A cox regression model will be used to calculate the hazard ratio for the incidence of ulcer recurrence. The change of barefoot dynamic plantar pressures will be assessed using repeated measures ANOVA. The study protocol has been approved by the Ethics Committee of The Biomedical Research Ethics Committee of West China Hospital, Sichuan University (Reference No. 2019(96)). DISCUSSION: This clinical trial will give information on the ability of novel diabetic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration. If the optimally designed therapeutic footwear does work well, the findings will contribute to the development of innovative treatment devices for preventing foot ulcer recurrence in high-risk patients. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900025538 . Registered on 31 August 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gao Y, Wang C, Chen D, et al. Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial. Trials. 2021. PMID: 33597005. doi:10.1186/s13063-021-05098-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。